IGI Logo

Below is quote on Supriya Lifescience Limited IPO subscribed 3.07 times on Day -2 By Mr. Yash Gupta, Equity Research Analyst, Angel One Ltd   

Supriya Lifescience Limited IPO received good response from retail investors, overall IPO subscribed 3.07 times and retail portion subscribed more than 15 times. Non institutional investors (NII) and Qualified institutional buyer (QIB) have not shown much response as of now, we have seen in earlier IPOs that both investors apply on the 3rd day or the last day of the IPO. 

We have a Subscribe rating on Supriya Lifescience Limited IPO, IPO has been priced at an EV/EBITDA of 11.2 times and price to earnings of 16.2 times at the upper price band of the IPO. . Supriya Lifescience Limited focuses on research & development and having a diversified niche product portfolio of API’s. Companies 77.5% of revenue comes from the Export market, companies’ key markets are USA, Europe, China and India. We believe that the company's new manufacturing unit and product launch will be growth drivers for the company in future.

Above views are of the author and not of the website kindly read disclaimer